Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: May 2023

Approval provided for Angelini’s cenobamate

Treatment will now be used across Ireland among adults with focal onset seizures with epilepsy

May 16, 2023 Uncategorized

Did the FDA break its own rules in approving the antibiotic Recarbrio?

Since the 1960s, in the wake of the thalidomide tragedy, the US has required drug makers to provide […]

May 16, 2023 Infectious diseases, US, Investigation, Data campaign

The decline of science at the FDA has become unmanageable

Before 1962, US federal law did not require pre-marketing proof of effectiveness for drugs. But senate hearings revealing […]

May 16, 2023 US, Too much medicine

Artificial sweeteners do not aid weight loss or improve health, says WHO

Artificial sweeteners and foods that contain them should not be used to try to control body weight or […]

May 15, 2023 Uncategorized

Primary care access plan could help narrow health inequalities, says pharmacy leader

The government’s plan to boost access to primary care by enhancing the role of community pharmacists offers the […]

May 15, 2023 General practice / family medicine

Christie: Regulator downgrades leading cancer centre amid bullying concerns

A top cancer centre’s leadership rating has been downgraded from “outstanding” to “requires improvement” by the Care Quality […]

May 15, 2023 Uncategorized

Institutionalising community engagement for quality of care: moving beyond the rhetoric

Key messagesComprehensive and appropriate community engagement is critical for quality improvement initiatives and improving health outcomes for communitiesToo […]

May 15, 2023 Uncategorized

Reviving the NHS—lessons from Labour 1997-2005

We have a great deal to learn from the period 1997 to 2005 when, as the King’s Fund […]

May 15, 2023 Uncategorized

Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial

This paper by Pichler and colleagues (BMJ 2023;380:e072313, doi:10.1136/bmj-2022-072313, published 24 January 2023) has been corrected in several […]

May 15, 2023 Uncategorized

NHS patients gain access to Gilead’s Hepcludex

NICE’s decision will result in eligible patients using a treatment that slows or halts aspects of the illness

May 15, 2023 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 13 14 15 … 24 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy